Loading
A phase 1 trial of SGR-3515 run by Schrödinger, Inc., now recruiting.
Study of SGR-3515 In Participants With Advanced Solid Tumors. is a phase 1 interventional study registered as NCT06463340 by Schrödinger, Inc., with 52 participants planned, started 2024-06-18. Conditions recorded: Advanced Solid Tumor. Interventions recorded: SGR-3515.
Shares Schrödinger, Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Schrödinger and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/